6.3.5.5. adjuvant systemic therapy n0 disease. adjuvant androgen ablation bicalutamide 150 mg daily improve pfs localised disease locally-advanced disease rt. however, never translated os benefit . sr showed possible benefit pfs os adjuvant androgen ablation . tax3501 trial comparing role leuprolide (18 months) without docetaxel (6 cycles) ended prematurely due poor accrual. phase iii rct comparing adjuvant docetaxel surveillance rp locally-advanced pca showed adjuvant docetaxel confer oncological benefit . consequently, adjuvant chemotherapy rp considered clinical trial .